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Biographies are usually written about indi-
viduals who have fascinated us because of
their accomplishments, opinions, or legacy.
Although Western civilization recognizes
the stories of the lives of biblical per-
sons as well Greek and Roman philoso-
phers and leaders, English literature attrib-
utes the first English biography to that of
Samuel Johnson by James Boswell because
of the detailed research which formulated
the description of Samuel Johnson and the
objectivity with which it was written. His-
torical biographies relate the biography to
concurrent historical events and provide a
historical background to the events of the
person’s time. These kinds of biographies
enlighten the reader on both the history
of the time and its impact on the indi-
vidual and when relevant to the role that
the individual played in shaping the his-
torical events. Historical fiction is a genre,
which creates a fictional story surrounding
real historical events. Although this genre
has been spawned, in part, by the desire
to learn more about a person or a period
of history, it can sometimes be challenging
for the reader to separate the fiction from
the “reality” of history. All of these genres
are enjoyable reading or escapes to another
time and place for the reader.
The recent paper by Barton et al. (1)
perhaps warrants defining a new genre –
historical biography for translational med-
icine. The criteria for this genre should
encompass (i) an accurate and compre-
hensive chronology of the relevant events
and dates of the biographee, (ii) a descrip-
tion of the medical science at the time
and the scientific question(s) that was
(were) addressed, (iii) the other scien-
tists/physicians who advanced the field to
that point in time, (iv) the nature of the
advancement made by the biographee, (v)
the nature of the scientific obstacles that
had to be overcome, (vi) the manner or
method by which the person overcame the
obstacles, (v) the method or manner of the
advance from the fundamental research to
clinical medicine, and (vii) the methods
by which the person overcame the road
blocks to the widespread utilization of the
methodology and/or its utilization in the
community or population at large.
Barton and co-authors have masterfully
accomplished this task in their biography
of Andreas Gruntzig. While there have been
other biographies of this pioneer in the
field of angioplasty, the biography by Bar-
ton and co-authors not only provides new
details about their subject, obtained from
newly identified documents and personal
accounts from co-workers, but also pro-
vides considerable more insights into the
character of the man and the challenges
that he faced. This article accomplishes
all of the above criteria for a historical
biography for translational medicine.
Translational medicine or translational
science in the field of medicine has
attracted considerable recent attention. It
grew from the concerns that the explosion
of biomedical basic science was not being
translated into meaningful improvements
in patient care or not being accomplished
in an expeditious manner commensurate
with the large expenditures in research and
the growing needs to treat patients or pre-
vent disease occurrence (2). The problems
facing the translation of medical science
from basic research to widespread clini-
cal practice have been described and dis-
cussed (2, 3). Obstacles for translational
research have been dichotomized into two
roadblocks. The first roadblock (labeled
T1) refers to those obstacles impeding the
“transfer of new understandings of dis-
ease mechanisms gained in the labora-
tory into the development of new meth-
ods for diagnosis, therapy, and prevention,
and their first testing in humans” (2). A
second roadblock (T2) occurs at the level
of “the translation of results from clini-
cal studies into everyday clinical practice
and health decision making.” (2). Each of
these roadblocks can have different ori-
gins and set of characteristics. It is likely
that there are a number of important
basic research accomplishments that have
not been translated into clinical medicine
because of T1 blocks. Similarly, there are
likely useful procedures that have not over-
come T2 blocks. Thus, there is a need
to learn from people such as Andreas
Gruntzig who successfully overcome these
roadblocks.
In some curriculum, medical students
are required to read a biography of a major
medical figure. This exercise is designed to
commemorate medical pioneers and pro-
vide a history of the biomedical tradition
as part of a medical education. Histori-
cal biography for translational medicine
can provide medical students and senior
faculty with an understanding of how
to overcome roadblocks in translational
medicine.
To some extent, the accomplishments
of a great person cannot be replicated by
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others without such talent. The charac-
teristics, however, are still instructive and
provide us with guideposts for career learn-
ing. What have we learned about Andreas
Gruntzig from this biography? Success was
accomplished by dedication, persistence,
hard work, passion, unwavering dedication
to attain the goal, and not being defeated by
rejection. His comment that “I have dedi-
cated my life to vascular disease” (1) stands
in contrast to the often banal comment one
might hear from many persons on their
choice of career. The intensity of the “inner
fire” that drove Andreas Gruntzig was evi-
dent to those around him (1). The intensity
of his passion, however, did not prevent
him from making friends in the field, some
of whom were instrumental in overcoming
the roadblocks.
Andreas Gruntzig was well trained in
medicine and research as well as being
exposed to leading medical “thinkers” and
teachers in his training. This training
included areas that superficially did not
appear to be directly related to angio-
plasty such as public health and epidemi-
ology but likely shaped his mode of think-
ing and problem solving. His education
played a role in creating or nurturing
the characteristics that are necessary for
translational medicine. Hard work with-
out any early recognition characterized his
early years; “without any support from
the federal funding agencies, working at
home in the evenings and on weekends
in addition to his full-time clinical duties,
Grüntzig had succeeded in having func-
tional, hand-made balloon catheters at his
disposal” (1).
Medical administrative leadership, at its
best fosters, creativity, and good biomed-
ical science. At its worst, medical admin-
istration can throttle or extinguish great
ideas and projects. Several times Andreas
Gruntzig was discouraged from or told that
he would not be able to do coronary angio-
plasty at his institutions. His persistence
undoubtedly did not win him favor with
his superiors or at his home institutions.
Persistence in seeking out like minded indi-
viduals, however, was necessary for him to
develop his concepts and techniques.
Barton and colleagues document
through meticulous research, the many
physicians and scientists who advanced
the field to that point from where Andreas
Guntzig made his leap forward (1). This
kind of information pays tribute to indi-
viduals whose major contributions were
the essential foundation of the field. It
also recalls the medieval comment, later
made famous by Sir Isaac Newton that
one sees further standing “on the shoulder
of giants” (4). In addition, the advance-
ment of coronary angioplasty required a
number of individuals who recognized the
value of the work being done by Andreas
Gruntzig and permitted him to proceed
with his plans without necessarily directly
contributing to the intellectual property
of coronary angioplasty. Barton and col-
leagues document, the contribution of
these facilitators and colleagues as well.
Andreas Gruntzig overcame the road
blocks to the widespread utilization of
coronary angioplasty by developing and
leading teaching sessions and seminars on
his techniques. These sessions drew peo-
ple’s attention and kindled the “inner fire”
in others to spread the technology to dif-
ferent medical centers.
Historical biographies for translational
medicine need to be written by experts in
the field together with those who know
the details of the life and times of the
biographee. It requires detailed research
and the capacity to explain the biomedical
issues, the process involved and the techni-
cal details of the subject matter. The value
of the excellent contribution by Barton
et al. (1) not only provides us with medical
history and commemorates the advance
but also provides us with important lessons
to overcome some of the contemporary
challenges in translational medicine.
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